Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected Patients

od Hawkins, Trevor, Veikley, Wenoah, Durand-Gasselin, Lucie, Babusis, Darius, Reddy, Y. Sunila, Flaherty, John F., Ray, Adrian S.
Izdano 2011

Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients

od Gupta, Samir K., Anderson, Albert M., Ebrahimi, Ramin, Fralich, Todd, Graham, Hiba, Scharen-Guivel, Valeska, Flaherty, John F., Fortin, Claude, Kalayjian, Robert C., Rachlis, Anita, Wyatt, Christina M.
Izdano 2014

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

od Gordon, Stuart C, Krastev, Zahary, Horban, Andrzej, Petersen, Jörg, Sperl, Jan, Dinh, Phillip, Martins, Eduardo B, Yee, Leland J, Flaherty, John F, Kitrinos, Kathryn M, Rustgi, Vinod K, Marcellin, Patrick
Izdano 2013

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

od Lok, Anna S., Zoulim, Fabien, Dusheiko, Geoffrey, Chan, Henry L.Y., Buti, Maria, Ghany, Marc G., Gaggar, Anuj, Yang, Jenny C., Wu, George, Flaherty, John F., Subramanian, G. Mani, Locarnini, Stephen, Marcellin, Patrick
izdano v Hepatol Commun (2019)

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective coh...

od Lampertico, Pietro, Berg, Thomas, Buti, Maria, Pathil, Anita, Petersen, Joerg, Ryder, Stephen D., Zoulim, Fabien, Botros, Irina, Flaherty, John F., Jump, Belinda, Op den Brouw, Marjoleine L., van Troostenburg, Anna, Ramroth, Heribert
izdano v Aliment Pharmacol Ther (2020)

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

od Buti, Maria, Tsai, Naoky, Petersen, Joerg, Flisiak, Robert, Gurel, Selim, Krastev, Zahary, Aguilar Schall, Raul, Flaherty, John F., Martins, Eduardo B., Charuworn, Prista, Kitrinos, Kathryn M., Mani Subramanian, G., Gane, Edward, Marcellin, Patrick
izdano v Dig Dis Sci (2014)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

od Pan, Calvin Q., Chang, Ting-Tsung, Bae, Si Hyun, Brunetto, Maurizia, Seto, Wai-Kay, Coffin, Carla S., Tan, Susanna K., Mo, Shuyuan, Flaherty, John F., Gaggar, Anuj, Nguyen, Mindie H., Çelen, Mustafa Kemal, Thompson, Alexander, Gane, Edward J.
izdano v PLoS One (2021)

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

od Buti, Maria, Fung, Scott, Gane, Edward, Afdhal, Nezam H., Flisiak, Robert, Gurel, Selim, Flaherty, John F., Martins, Eduardo B., Yee, Leland J., Dinh, Phillip, Bornstein, Jeffrey D., Mani Subramanian, G., Janssen, Harry L. A., George, Jacob, Marcellin, Patrick
izdano v Hepatol Int (2015)

Single-Dose and Steady-State Pharmacokinetics of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Children

od Hazra, Rohan, Balis, Frank M., Tullio, Antonella N., DeCarlo, Ellen, Worrell, Carol J., Steinberg, Seth M., Flaherty, John F., Yale, Kitty, Poblenz, Marianne, Kearney, Brian P., Zhong, Lijie, Coakley, Dion F., Blanche, Stephane, Bresson, Jean Louis, Zuckerman, Judith A., Zeichner, Steven L.
Izdano 2004

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

od Marcellin, Patrick, Buti, Maria, Krastev, Zahari, de Man, Robert A., Zeuzem, Stefan, Lou, Lillian, Gaggar, Anuj, Flaherty, John F., Massetto, Benedetta, Lin, Lanjia, Dinh, Phillip, Subramanian, G. Mani, McHutchison, John G., Flisiak, Robert, Gurel, Selim, Dusheiko, Geoffrey M., Heathcote, E. Jenny
izdano v J Hepatol (2014)

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection

od Cathcart, Andrea L., Chan, Henry Lik-Yuen, Bhardwaj, Neeru, Liu, Yang, Marcellin, Patrick, Pan, Calvin Q., Shalimar, Buti, Maria, Cox, Stephanie, Parhy, Bandita, Zhou, Eric, Martin, Ross, Chang, Silvia, Lin, Lanjia, Flaherty, John F., Kitrinos, Kathryn M., Gaggar, Anuj, Izumi, Namiki, Lim, Young-Suk
izdano v Antimicrob Agents Chemother (2018)

3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China

od Hou, Jinlin, Ning, Qin, Duan, Zhongping, Chen, You, Xie, Qing, Wang, Fu-Sheng, Zhang, Lunli, Wu, Shanming, Tang, Hong, Li, Jun, Lin, Feng, Yang, Yongfeng, Gong, Guozhong, Flaherty, John F., Gaggar, Anuj, Mo, Shuyuan, Cheng, Cong, Camus, Gregory, Chen, Chengwei, Huang, Yan, Jia, Jidong, Zhang, Mingxiang
izdano v J Clin Transl Hepatol (2021)